Monoclonal Antibody Therapeutics Market - Global Outlook and Forecast 2022-2028

January 2022 | 66 pages | ID: ME6F6A27992CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Monoclonal Antibody Therapeutics in Global, including the following market information:

Global Monoclonal Antibody Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Monoclonal Antibody Therapeutics market was valued at 117490 million in 2021 and is projected to reach US$ 186150 million by 2028, at a CAGR of 6.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Humanized Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Monoclonal Antibody Therapeutics include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monoclonal Antibody Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Monoclonal Antibody Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Monoclonal Antibody Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Humanized Antibody
• Human Mouse Chimeric Antibody

Global Monoclonal Antibody Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Monoclonal Antibody Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Autoimmune Diseases
• Infection
• Hematological Diseases
• Ophthalmological Diseases
• Others

Global Monoclonal Antibody Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Monoclonal Antibody Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Monoclonal Antibody Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Monoclonal Antibody Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• F. Hoffmann-La Roche
• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck
• Novartis
• AbbVie
• Amgen
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Biogen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Monoclonal Antibody Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Monoclonal Antibody Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MONOCLONAL ANTIBODY THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Monoclonal Antibody Therapeutics Market Size: 2021 VS 2028
2.2 Global Monoclonal Antibody Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Monoclonal Antibody Therapeutics Players in Global Market
3.2 Top Global Monoclonal Antibody Therapeutics Companies Ranked by Revenue
3.3 Global Monoclonal Antibody Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Monoclonal Antibody Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Monoclonal Antibody Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monoclonal Antibody Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Monoclonal Antibody Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Monoclonal Antibody Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Monoclonal Antibody Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Humanized Antibody
  4.1.3 Human Mouse Chimeric Antibody
4.2 By Type - Global Monoclonal Antibody Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Monoclonal Antibody Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Monoclonal Antibody Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Monoclonal Antibody Therapeutics Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Autoimmune Diseases
  5.1.4 Infection
  5.1.5 Hematological Diseases
  5.1.6 Ophthalmological Diseases
  5.1.7 Others
5.2 By Application - Global Monoclonal Antibody Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Monoclonal Antibody Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Monoclonal Antibody Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Monoclonal Antibody Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Monoclonal Antibody Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Monoclonal Antibody Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Monoclonal Antibody Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Monoclonal Antibody Therapeutics Revenue, 2017-2028
  6.3.2 US Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.3.3 Canada Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Monoclonal Antibody Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Monoclonal Antibody Therapeutics Revenue, 2017-2028
  6.4.2 Germany Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.4.3 France Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.4.5 Italy Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.4.6 Russia Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Monoclonal Antibody Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Monoclonal Antibody Therapeutics Revenue, 2017-2028
  6.5.2 China Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.5.3 Japan Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.5.6 India Monoclonal Antibody Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Monoclonal Antibody Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Monoclonal Antibody Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Monoclonal Antibody Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.7.3 Israel Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Monoclonal Antibody Therapeutics Market Size, 2017-2028
  6.7.5 UAE Monoclonal Antibody Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Monoclonal Antibody Therapeutics Major Product Offerings
  7.1.4 Bayer Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 F. Hoffmann-La Roche
  7.2.1 F. Hoffmann-La Roche Corporate Summary
  7.2.2 F. Hoffmann-La Roche Business Overview
  7.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Monoclonal Antibody Therapeutics Major Product Offerings
  7.3.4 Pfizer Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Monoclonal Antibody Therapeutics Major Product Offerings
  7.4.4 Sanofi Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Major Product Offerings
  7.5.4 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Monoclonal Antibody Therapeutics Major Product Offerings
  7.6.4 Merck Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Monoclonal Antibody Therapeutics Major Product Offerings
  7.7.4 Novartis Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 AbbVie
  7.8.1 AbbVie Corporate Summary
  7.8.2 AbbVie Business Overview
  7.8.3 AbbVie Monoclonal Antibody Therapeutics Major Product Offerings
  7.8.4 AbbVie Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 AbbVie Key News
7.9 Amgen
  7.9.1 Amgen Corporate Summary
  7.9.2 Amgen Business Overview
  7.9.3 Amgen Monoclonal Antibody Therapeutics Major Product Offerings
  7.9.4 Amgen Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Amgen Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Major Product Offerings
  7.10.4 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Johnson & Johnson Key News
7.11 Bristol-Myers Squibb Company
  7.11.1 Bristol-Myers Squibb Company Corporate Summary
  7.11.2 Bristol-Myers Squibb Company Business Overview
  7.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Major Product Offerings
  7.11.4 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Bristol-Myers Squibb Company Key News
7.12 Biogen
  7.12.1 Biogen Corporate Summary
  7.12.2 Biogen Business Overview
  7.12.3 Biogen Monoclonal Antibody Therapeutics Major Product Offerings
  7.12.4 Biogen Monoclonal Antibody Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Biogen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Monoclonal Antibody Therapeutics Market Opportunities & Trends in Global Market
Table 2. Monoclonal Antibody Therapeutics Market Drivers in Global Market
Table 3. Monoclonal Antibody Therapeutics Market Restraints in Global Market
Table 4. Key Players of Monoclonal Antibody Therapeutics in Global Market
Table 5. Top Monoclonal Antibody Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Monoclonal Antibody Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Monoclonal Antibody Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Monoclonal Antibody Therapeutics Product Type
Table 9. List of Global Tier 1 Monoclonal Antibody Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monoclonal Antibody Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Monoclonal Antibody Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Monoclonal Antibody Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Monoclonal Antibody Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Monoclonal Antibody Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Monoclonal Antibody Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Monoclonal Antibody Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Monoclonal Antibody Therapeutics Product Offerings
Table 32. Bayer Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Corporate Summary
Table 34. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product Offerings
Table 35. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Monoclonal Antibody Therapeutics Product Offerings
Table 38. Pfizer Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Monoclonal Antibody Therapeutics Product Offerings
Table 41. Sanofi Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Monoclonal Antibody Therapeutics Product Offerings
Table 44. GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Monoclonal Antibody Therapeutics Product Offerings
Table 47. Merck Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Monoclonal Antibody Therapeutics Product Offerings
Table 50. Novartis Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Monoclonal Antibody Therapeutics Product Offerings
Table 53. AbbVie Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Monoclonal Antibody Therapeutics Product Offerings
Table 56. Amgen Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Monoclonal Antibody Therapeutics Product Offerings
Table 59. Johnson & Johnson Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Bristol-Myers Squibb Company Corporate Summary
Table 61. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product Offerings
Table 62. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Biogen Corporate Summary
Table 64. Biogen Monoclonal Antibody Therapeutics Product Offerings
Table 65. Biogen Monoclonal Antibody Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Monoclonal Antibody Therapeutics Segment by Type in 2021
Figure 2. Monoclonal Antibody Therapeutics Segment by Application in 2021
Figure 3. Global Monoclonal Antibody Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Monoclonal Antibody Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Monoclonal Antibody Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2021
Figure 8. By Type - Global Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Monoclonal Antibody Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Monoclonal Antibody Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Biogen Monoclonal Antibody Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)